Mereo BioPharma News

Mereo BioPharma | EFFECT: Others

May 28 06:06 ET

Mereo BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Hughes-Wilson Alexandra

May 23 21:55 ET

Mereo BioPharma | 144: Notice of proposed sale of securities pursuant to Rule 144

May 23 18:40 ET

Mereo BioPharma | 8-K: Current report

May 23 16:20 ET

Mereo BioPharma | S-3: Registration statement for specified transactions by certain issuers

May 15 16:53 ET

Mereo BioPharma | 10-Q: Quarterly report

May 15 16:29 ET

Mereo BioPharma | 8-K: Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 15 16:18 ET

Mereo BioPharma | ARS: Annual Report to Security Holders

Apr 24 07:38 ET

Mereo BioPharma | DEF 14A: Definitive information statements

Apr 24 07:33 ET

Mereo BioPharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(14.22%),David Rosen(14.22%)

Apr 16 15:00 ET

Mereo BioPharma | 8-K: Current report

Apr 15 07:33 ET

Mereo BioPharma | 10-K: Annual report

Mar 27 17:25 ET

Mereo BioPharma | 8-K: Current report

Mar 27 16:11 ET

Mereo BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Capital GP VII LLC(0.0%),OrbiMed Advisors LLC(0.0%), etc.

Feb 14 18:53 ET

Mereo BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rock Springs Capital Management LP(6.38%),Rock Springs Capital LLC(6.38%), etc.

Feb 14 14:13 ET

Mereo BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rock Springs Capital Management LP(5.69%),Rock Springs Capital LLC(5.69%), etc.

Feb 14 14:13 ET

Mereo BioPharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mangrove Partners IM, LLC(6.24%),Nathaniel August(6.24%)

Feb 14 12:38 ET

Mereo BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(5.3%),Averill Master Fund, Ltd.(5.3%), etc.

Feb 13 17:35 ET

Mereo BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Yoskowitz Marc J

Feb 9 16:22 ET

Mereo BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Jacquet Pierre

Feb 9 16:22 ET